GB0408199D0 - Liquids containing suspended sugar glass particles - Google Patents
Liquids containing suspended sugar glass particlesInfo
- Publication number
- GB0408199D0 GB0408199D0 GBGB0408199.8A GB0408199A GB0408199D0 GB 0408199 D0 GB0408199 D0 GB 0408199D0 GB 0408199 A GB0408199 A GB 0408199A GB 0408199 D0 GB0408199 D0 GB 0408199D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- glass particles
- liquids containing
- containing suspended
- particles
- sugar glass
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000002245 particle Substances 0.000 title abstract 4
- 239000011521 glass Substances 0.000 title abstract 2
- 239000007788 liquid Substances 0.000 title abstract 2
- 229920001774 Perfluoroether Polymers 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 230000002776 aggregation Effects 0.000 abstract 1
- 238000004220 aggregation Methods 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 229910000389 calcium phosphate Inorganic materials 0.000 abstract 1
- 239000001506 calcium phosphate Substances 0.000 abstract 1
- 235000011010 calcium phosphates Nutrition 0.000 abstract 1
- 150000007942 carboxylates Chemical class 0.000 abstract 1
- 229910052751 metal Inorganic materials 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- GVGCUCJTUSOZKP-UHFFFAOYSA-N nitrogen trifluoride Chemical compound FN(F)F GVGCUCJTUSOZKP-UHFFFAOYSA-N 0.000 abstract 1
- UJMWVICAENGCRF-UHFFFAOYSA-N oxygen difluoride Chemical compound FOF UJMWVICAENGCRF-UHFFFAOYSA-N 0.000 abstract 1
- 239000010702 perfluoropolyether Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- QTJXVIKNLHZIKL-UHFFFAOYSA-N sulfur difluoride Chemical compound FSF QTJXVIKNLHZIKL-UHFFFAOYSA-N 0.000 abstract 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Glass Compositions (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (18)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0408199.8A GB0408199D0 (en) | 2004-04-13 | 2004-04-13 | Liquids containing suspended sugar glass particles |
| GB0504501A GB2413075B (en) | 2004-04-13 | 2005-03-07 | Liquids containing suspended glass particles |
| AT05731023T ATE457717T1 (de) | 2004-04-13 | 2005-04-13 | Flüssigkeiten mit suspendierten glasteilchen |
| MXPA06011895A MXPA06011895A (es) | 2004-04-13 | 2005-04-13 | Liquidos que contienen particulas de vidrio suspendidas. |
| KR1020067022106A KR20070009639A (ko) | 2004-04-13 | 2005-04-13 | 부유 유리 입자를 함유한 액체 |
| JP2007507853A JP2007532619A (ja) | 2004-04-13 | 2005-04-13 | 懸濁したガラス粒子を含有する液体 |
| CA002562606A CA2562606A1 (en) | 2004-04-13 | 2005-04-13 | Liquids containing suspended glass particles |
| PT05731023T PT1750668E (pt) | 2004-04-13 | 2005-04-13 | Líquidos contendo partículas de vidro em suspensão |
| AU2005232441A AU2005232441B2 (en) | 2004-04-13 | 2005-04-13 | Liquids containing suspended glass particles |
| DE602005019398T DE602005019398D1 (de) | 2004-04-13 | 2005-04-13 | Flüssigkeiten mit suspendierten glasteilchen |
| PCT/GB2005/050050 WO2005099669A1 (en) | 2004-04-13 | 2005-04-13 | Liquids containing suspended glass particles |
| EP05731023A EP1750668B1 (en) | 2004-04-13 | 2005-04-13 | Liquids containing suspended glass particles |
| CN2005800110373A CN1942171B (zh) | 2004-04-13 | 2005-04-13 | 含有悬浮玻璃状粒子的液体 |
| US10/599,928 US20080026066A1 (en) | 2004-04-13 | 2005-04-13 | Liquids Containing Suspended Glass Particles |
| DK05731023.7T DK1750668T3 (da) | 2004-04-13 | 2005-04-13 | Væsker, der indeholder suspenderede glaspartikler |
| RU2006137275/15A RU2363447C2 (ru) | 2004-04-13 | 2005-04-13 | Жидкости, содержащие суспендированные стекловидные частицы |
| ES05731023T ES2339783T3 (es) | 2004-04-13 | 2005-04-13 | Liquidos que contienen particulas vitreas suspendidas. |
| ZA200609158A ZA200609158B (en) | 2004-04-13 | 2006-11-03 | Liquids containing suspended glass particles |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0408199.8A GB0408199D0 (en) | 2004-04-13 | 2004-04-13 | Liquids containing suspended sugar glass particles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0408199D0 true GB0408199D0 (en) | 2004-05-19 |
Family
ID=32320732
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB0408199.8A Ceased GB0408199D0 (en) | 2004-04-13 | 2004-04-13 | Liquids containing suspended sugar glass particles |
| GB0504501A Expired - Lifetime GB2413075B (en) | 2004-04-13 | 2005-03-07 | Liquids containing suspended glass particles |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB0504501A Expired - Lifetime GB2413075B (en) | 2004-04-13 | 2005-03-07 | Liquids containing suspended glass particles |
Country Status (10)
| Country | Link |
|---|---|
| CN (1) | CN1942171B (da) |
| AT (1) | ATE457717T1 (da) |
| DE (1) | DE602005019398D1 (da) |
| DK (1) | DK1750668T3 (da) |
| ES (1) | ES2339783T3 (da) |
| GB (2) | GB0408199D0 (da) |
| MX (1) | MXPA06011895A (da) |
| PT (1) | PT1750668E (da) |
| RU (1) | RU2363447C2 (da) |
| ZA (1) | ZA200609158B (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0517688D0 (en) * | 2005-08-31 | 2005-10-05 | Cambridge Biostability Ltd | Improvements in the stabilisation of biological materials |
| GB0523638D0 (en) | 2005-11-21 | 2005-12-28 | Cambridge Biostability Ltd | Pharmaceutical device for the administration of substances to patients |
| US9243626B2 (en) | 2012-11-19 | 2016-01-26 | Nordson Corporation | Adhesive dispensing system and method including a pump with integrated diagnostics |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07258027A (ja) * | 1994-03-16 | 1995-10-09 | Shiseido Co Ltd | メーキャップ化粧料 |
| US6433040B1 (en) * | 1997-09-29 | 2002-08-13 | Inhale Therapeutic Systems, Inc. | Stabilized bioactive preparations and methods of use |
| US6190701B1 (en) * | 1999-03-17 | 2001-02-20 | Peter M. Ronai | Composition and method for stable injectable liquids |
| AU2046101A (en) * | 1999-11-22 | 2001-06-04 | Universal Preservation Technologies, Inc. | Preservation and formulation of bioactive materials for storage and delivery in hydrophobic carriers |
| KR20030039363A (ko) * | 2000-07-20 | 2003-05-17 | 오뜨끄리또에 악찌오네르노에 오브셰스뜨보 나우취노-쁘로이즈보드스뜨벤나야 피르마 "뻬르프또란" | 의료용 퍼플루오르 유기화합물의 유제 및 그 제조방법 및그것을 이용한 질병 치료 및 예방방법 |
| PL360052A1 (en) * | 2000-10-13 | 2004-09-06 | Cambridge Biostability Ltd. | Composition and method for stable injectable liquids |
-
2004
- 2004-04-13 GB GBGB0408199.8A patent/GB0408199D0/en not_active Ceased
-
2005
- 2005-03-07 GB GB0504501A patent/GB2413075B/en not_active Expired - Lifetime
- 2005-04-13 CN CN2005800110373A patent/CN1942171B/zh not_active Expired - Fee Related
- 2005-04-13 PT PT05731023T patent/PT1750668E/pt unknown
- 2005-04-13 DK DK05731023.7T patent/DK1750668T3/da active
- 2005-04-13 DE DE602005019398T patent/DE602005019398D1/de not_active Expired - Lifetime
- 2005-04-13 AT AT05731023T patent/ATE457717T1/de not_active IP Right Cessation
- 2005-04-13 ES ES05731023T patent/ES2339783T3/es not_active Expired - Lifetime
- 2005-04-13 RU RU2006137275/15A patent/RU2363447C2/ru not_active IP Right Cessation
- 2005-04-13 MX MXPA06011895A patent/MXPA06011895A/es unknown
-
2006
- 2006-11-03 ZA ZA200609158A patent/ZA200609158B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200609158B (en) | 2008-06-25 |
| DK1750668T3 (da) | 2010-05-10 |
| ES2339783T3 (es) | 2010-05-25 |
| CN1942171B (zh) | 2011-04-06 |
| GB2413075B (en) | 2009-01-21 |
| RU2006137275A (ru) | 2008-05-20 |
| DE602005019398D1 (de) | 2010-04-01 |
| GB0504501D0 (en) | 2005-04-13 |
| ATE457717T1 (de) | 2010-03-15 |
| MXPA06011895A (es) | 2007-11-20 |
| PT1750668E (pt) | 2010-04-07 |
| GB2413075A (en) | 2005-10-19 |
| CN1942171A (zh) | 2007-04-04 |
| RU2363447C2 (ru) | 2009-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2335575A3 (en) | Magnetic gas bubble composition and magnetic gas bubble precursor for its manufacture | |
| UA96473C2 (ru) | Жидкая стойкая композиция, которая содержит антитело imc-а12 | |
| GB2464038A (en) | System, method, and apparatus for combined fracturing treatment and scale inhibition | |
| DK1435916T3 (da) | Pulverbearbejdning med tryksatte gasformige fluider | |
| UA106925C2 (uk) | Пробіотичні композиції, способи та пристрій для їх введення | |
| WO2004058156A3 (en) | High pressure spray-dry of bioactive materials | |
| CO5660273A2 (es) | Formulaciones de proteina y anticuerpo de alta concentracion | |
| EP2293808A4 (en) | BONE FORMING PEPTIDE 1 (BFP1) CONTAINING SYNTHETIC PEPTIDE FOR STIMULATING OSTEOBLASTINE DIFFERENTIATION AND THE SYNTHETIC PEPTIDE-CONTAINING PHARMACEUTICAL COMPOSITION | |
| MX271467B (es) | Composicion para la limpieza personal que contiene particulas de forma irregular y particulas esfericas. | |
| PL2007863T3 (pl) | Granulat wrażliwego składnika środków piorących lub czyszczących | |
| CA2521007A1 (en) | Particulate material containing thermoplastic elastomer and methods for making and using same | |
| BR0214279A (pt) | Composições farmacêuticas em forma particulada | |
| NZ596876A (en) | Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same | |
| WO2006137934A3 (en) | Purposeful movement of human migratory cells away from an agent source | |
| SE0100823D0 (sv) | Method I to obtain microparticles | |
| UA96145C2 (ru) | Жиросодержащая композиция и способ улучшения растворимости жиросодержащих порошков в холодных жидкостях | |
| WO2009060608A1 (ja) | Ｓｄｆ－１を含有してなる徐放性組成物 | |
| NZ599292A (en) | Vitamin d compositions and method of administration to a human being | |
| MA31927B1 (fr) | Compositions pharmaceutiques renfermant au moins un principe actif proteinique protege des enzymes digestives | |
| FR2881648B1 (fr) | Composition cosmetique comprenant une dispersion de particules de polymeres, dispersion de particules de polymeres et procede cosmetique l'utilisant | |
| GB2413075B (en) | Liquids containing suspended glass particles | |
| ATE458256T1 (de) | Magnetorheologische materialien mit hohem schaltfaktor und deren verwendung | |
| WO2003016563A3 (fr) | Cible moleculaire de la neurotoxicite | |
| TR200102988T2 (tr) | Kompleks sıvıların idare edilmesinde kullanmak için emiciler. | |
| EP1839685A3 (en) | Bearing material for a medical implant |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) | ||
| COOA | Change in applicant's name or ownership of the application |
Owner name: NOVA BIO-PHARMA TECHNOLOGIES LIMITED Free format text: FORMER OWNER: CAMBRIDGE BIOSTABILITY LIMITED |